相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe
P. Bertuccio et al.
ANNALS OF ONCOLOGY (2013)
FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience
Roberto Moretto et al.
ANTI-CANCER DRUGS (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer
Eiichiro Suzuki et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
A Retrospective Study of Gemcitabine and Cisplatin Combination Therapy as Second-Line Treatment for Advanced Biliary Tract Cancer
Takashi Sasaki et al.
CHEMOTHERAPY (2013)
Outcome of second-line chemotherapy for biliary tract cancer
John Bridgewater et al.
EUROPEAN JOURNAL OF CANCER (2013)
Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: A large retrospective study
Thomas Walter et al.
EUROPEAN JOURNAL OF CANCER (2013)
Improvement of prognosis for unresectable biliary tract cancer
Takashi Sasaki et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: A multicentre, multinational study
Jun Ho Yi et al.
EUROPEAN JOURNAL OF CANCER (2012)
Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine
Takashi Sasaki et al.
INVESTIGATIONAL NEW DRUGS (2012)
A Retrospective Study of S-1 Monotherapy as Second-line Treatment for Patients with Advanced Biliary Tract Cancer
Satoshi Kobayashi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2012)
Phase II Trial of Erlotinib and Docetaxel in Advanced and Refractory Hepatocellular and Biliary Cancers: Hoosier Oncology Group GI06-101
Elena Gabriela Chiorean et al.
ONCOLOGIST (2012)
Outcome of Infusional 5-Fluorouracil, Doxorubicin, and Mitomycin-C (iFAM) Chemotherapy and Analysis of Prognostic Factors in Patients with Refractory Advanced Biliary Tract Cancer
Kyu-Hyoung Lim et al.
ONCOLOGY (2012)
Phase II study of second line gemcitabine single chemotherapy for biliary tract cancer patients with 5-fluorouracil refractoriness
Sung Yong Oh et al.
INVESTIGATIONAL NEW DRUGS (2011)
Feasibility study of gemcitabine and cisplatin combination chemotherapy for patients with refractory biliary tract cancer
Takashi Sasaki et al.
INVESTIGATIONAL NEW DRUGS (2011)
Imatinib Mesylate for Palliative Second-Line Treatment of Advanced Biliary Tract Cancer: A Bicentric Phase II Study
Annekathrin Roth et al.
ONKOLOGIE (2011)
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
T. Okusaka et al.
BRITISH JOURNAL OF CANCER (2010)
Efficacy and safety of RAD001 in advanced biliary tract cancer (BTC) patients (pts) progressing after first-line chemotherapy: A phase II study.
R. Buzzoni et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study
Andrew X. Zhu et al.
LANCET ONCOLOGY (2010)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Second-Line Treatment With a Combination of Continuous 5-Fluorouracil, Doxorubicin, and Mitomycin-C (Conti-Fam) in Gemcitabine-Pretreated Pancreatic and Biliary Tract Cancer
Suee Lee et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2009)
Capecitabine and Celecoxib as Second-Line Treatment of Advanced Pancreatic and Biliary Tract Cancers
Maria S. Pino et al.
ONCOLOGY (2009)
S-1 Monotherapy in Patients with Advanced Biliary Tract Cancer
Takashi Sasaki et al.
ONCOLOGY (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Phase II trial of oxaliplatin combined with leucovorin and fluorouracil for rccurrent/metastatic biliary tract carcinoma
Jae Yun Lim et al.
ANTI-CANCER DRUGS (2008)
Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials
F. Eckel et al.
BRITISH JOURNAL OF CANCER (2007)
Cetuximab plus gemcitabine-oxaliplatin (GEMOX) in patients with refractory advanced intrahepatic cholangiocarcinomas
Bernard Paule et al.
ONCOLOGY (2007)
Single-agent gemcitabine for biliary tract cancers - Study outcomes and systematic review of the literature
Takayoshi Kiba et al.
ONCOLOGY (2006)
Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma
S von Delius et al.
BMC CANCER (2005)
Weekly gemcitabine for the treatment of biliary tract and gallbladder cancer
N Tsavaris et al.
INVESTIGATIONAL NEW DRUGS (2004)
Gemcitabine and cisplatin combination chemotherapy in intrahepatic cholangiocarcinoma as second-line treatment: Report of four cases
MA Lee et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2004)
Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma
T Takada et al.
CANCER (2002)
Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States
T Patel
HEPATOLOGY (2001)
分享论文
